Nav: Home

Successful insomnia treatment may require nothing more than a placebo

February 21, 2017

A new study published in Brain indicates that successful treatment for insomnia may not actually require complicated neurofeedback (direct training of brain functions). Rather, it appears patients who simply believe they're getting neurofeedback training appear to get the same benefits.

Insomnia affects between 10 and 35% of the population worldwide. However, despite the burden of insomnia on our society, only few studies have addressed this issue non-pharmacologically. Researchers here recruited thirty patients with primary insomnia, who underwent neurofeedback treatment and placebo-feedback treatment over several weeks.

In the study researchers sought to test whether earlier findings on the positive effect of neurofeedback on sleep quality and memory could also be replicated in a double-blind placebo-controlled study. Patients spent nine nights and twelve sessions of neurofeedback and twelve sessions of placebo-feedback training (sham) in researchers' laboratory.

As this study focuses on neurofeedback effects on EEG, sleep and quality of life in insomnia patients, insomnia patients underwent this procedure before and after real as well as placebo neurofeedback training. In between the first and second, as well as the third and fourth of these visits insomnia patients completed twelve sessions of neurofeedback treatment and twelve sessions of placebo-feedback treatment, i.e. a placebo or sham condition (with real EEG feedback, yet on varying frequency bands). The order of trainings, that is, real or placebo neurofeedback treatment was counterbalanced across subjects and the twelve sessions were completed within 4 weeks. Participants' sleep-wake cycle was assessed using eight sleep laboratory nights, as well as sleep diaries and actigraphy over the course of the whole protocol.

Researchers found both neurofeedback and placebo-feedback to be equally effective as reflected in subjective measures of sleep complaints, suggesting that the observed improvements were due to unspecific factors such as experiencing trust and receiving care and empathy from experimenters. In addition, these improvements were not reflected in objective EEG-derived measures of sleep quality.

Researchers conclude that for the treatment of primary insomnia, neurofeedback does not have a specific efficacy beyond unspecific placebo effects. They did not find an advantage of neurofeedback over placebo-feedback.

The results show that patients benefitted from any treatment on some subjective measures of sleep and life quality. Objectively, however, this improvement was not verified in any EEG-derived measures of sleep or oscillatory brain activity.

"Given our results," said lead author Manuel Schabus, "one has to question how much of published neurofeeback effects are due to simple expectations on the side of the participants or, in other words, unspecific placebo effects".

Researchers find that improvement of symptoms was not specific to neurofeeback training, but rather seems to have been brought about by unspecific factors such as affection and care. Altogether, it therefore has to be questioned whether sensorimotor-rhythm neurofeedback can be promoted as an alternative to established therapeutic approaches. The findings may also stimulate a discussion regarding the usefulness of neurofeedback on a more general level. Especially in patient populations where various complaints are often associated with learning difficulties positive neurofeedback effects beyond the subjective level may be hard to achieve.
-end-
The paper, "Better than sham? - A double-blind placebo-controlled neurofeedback study in primary insomnia," is available at: https://academic.oup.com/DocumentLibrary/Brain/PR_Papers/awx011.pdf

Direct correspondence to:

Manuel Schabus, PhD University of Salzburg Hellbrunnerstr. 34, 5020 Salzburg, Austria; e-mail: Manuel.Schabus@sbg.ac.at

DOI: http://dx.doi.org/10.1093/brain/awx011

FUNDING:

Research was supported by the FWF research grant P-21154-B18 from the Austrian Science Fund. In addition this study was supported by the Doctoral College ''Imaging the Mind''(FWF; W1233) (D. Heib, and M. Wislowska).

To request a copy of the study, please contact:

Daniel Luzer
daniel.luzer@oup.com
212-743-6113

Sharing on social media? Find Oxford Journals online at @OxfordJournals

Oxford University Press USA

Related Insomnia Articles:

Disturbed childhood can lead to adult insomnia
Parents should help their children with better sleep patterns, along with any problem behavioural issues, because this can lead to severe insomnia in middle age, a groundbreaking new study shows.
Study compares different strategies for treating insomnia
New research published in Worldviews on Evidence-Based Nursing indicates that for treating insomnia, stimulus control therapy (which reassociates the bed with sleepiness instead of arousal) and sleep restriction therapy are effective, and it is best to use them individually rather than together.
Brain cells involved in insomnia identified
An international team of researchers has identified, for the first time, the cell types, areas and biological processes in the brain that mediate the genetic risk of insomnia.
Mice sleeping fitfully provide clues to insomnia
Researchers at Washington University School of Medicine in St. Louis -- working with mice with sleep problems similar to those experienced by people with the genetic disease neurofibromatosis type 1 (NF1) -- believe the animals will help shed light on insomnia linked to NF1 or other factors.
Insomnia has many faces
Researchers at the Netherlands Institute for Neuroscience revealed that there are five types of insomnia.
More Insomnia News and Insomnia Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...